Document Detail

Alpha-2 interferon and 5-fluorouracil in advanced colorectal cancer.
MedLine Citation:
PMID:  2205028     Owner:  NLM     Status:  MEDLINE    
A total of 21 untreated patients (5 males, 16 females; median age, 55 years; range, 28-72) with advanced measurable colorectal carcinoma were treated with an association of 5-fluorouracil (1000 mg/weekly) and alpha-2 interferon (three times a week s.c.: 6 x 10(6) U in the 1st month, 9 x 10(6) U in the 2nd month, 12 x 10(6) U in the 3rd month and then 18 x 10(6) U) until maximum response or progression of disease. Sites of disease involved liver in 10 patients, lung in 6, supraclavicular lymph nodes in 3, skin in 1, abdomen in 4, and vagina in 1 patient. Nine responses (42.8%) were documented (4 complete and 5 partial) with metastases confined to the liver, lung, nodes and skin. Median duration of response was 11 months (range, 4-17+) and median survival was 10 months (range, 2-17+). Side effects (fever, flu-like syndrome and leukopenia) required a dose reduction of 5-fluorouracil in 8 patients and interferon in 2 patients.
A Fornasiero; O Daniele; C Ghiotto; S M Aversa; P Morandi; M V Fiorentino
Related Documents :
21528668 - Lymph node harvesting in colorectal carcinoma specimens.
14581348 - Su5416 plus interferon alpha in advanced renal cell carcinoma: a phase ii california ca...
8791058 - Ultrastructural study of the noninvolved urothelium of tumor-bearing patients after two...
19020738 - Concurrent chemobiotherapy with cisplatin, dacarbazine, decrescendo interleukin-2 and i...
16863928 - External beam radiation therapy followed by high-dose-rate brachytherapy for inoperable...
17803678 - Monotherapy with low-dose thalidomide for relapsed or refractory multiple myeloma: bett...
Publication Detail:
Type:  Clinical Trial; Journal Article    
Journal Detail:
Title:  Tumori     Volume:  76     ISSN:  0300-8916     ISO Abbreviation:  Tumori     Publication Date:  1990 Aug 
Date Detail:
Created Date:  1990-10-18     Completed Date:  1990-10-18     Revised Date:  2008-12-12    
Medline Journal Info:
Nlm Unique ID:  0111356     Medline TA:  Tumori     Country:  ITALY    
Other Details:
Languages:  eng     Pagination:  385-8     Citation Subset:  IM    
Divisione di Oncologia Medica, U.S.S.L. 21 Padova, Italy.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Carcinoma / drug therapy,  pathology,  therapy*
Clinical Trials as Topic
Colorectal Neoplasms / drug therapy,  pathology,  therapy*
Drug Administration Schedule
Drug Therapy, Combination
Fluorouracil / administration & dosage,  adverse effects,  therapeutic use*
Interferon Type I, Recombinant / administration & dosage,  adverse effects,  therapeutic use*
Middle Aged
Neoplasm Staging
Reg. No./Substance:
0/Interferon Type I, Recombinant; 51-21-8/Fluorouracil

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Diet and epithelial cancer of the thyroid gland.
Next Document:  Malaria vaccines, a necessity for future control of malaria. Status and future perspectives